InspireMD (NSPR) Gross Profit Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.54% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 9.03% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.49% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.49% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.46% |
| 10 | InspireMD | 64.01 Mn | 9.80 Mn | 1.18 Mn | 81.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81.30% |
| Sep 30, 2025 | 33.15% |
| Jun 30, 2025 | -10.11% |
| Mar 31, 2025 | 33.76% |
| Dec 31, 2024 | 16.84% |
| Sep 30, 2024 | 65.10% |
| Jun 30, 2024 | 8.10% |
| Mar 31, 2024 | 40.18% |
| Dec 31, 2023 | 48.80% |
| Sep 30, 2023 | 13.70% |
| Jun 30, 2023 | 82.63% |
| Mar 31, 2023 | 8.13% |
| Dec 31, 2022 | -8.56% |
| Sep 30, 2022 | 41.94% |
| Jun 30, 2022 | -0.84% |
| Mar 31, 2022 | 54.27% |
| Dec 31, 2021 | 9.00% |
| Sep 30, 2021 | -22.55% |
| Jun 30, 2021 | -1.84% |
| Mar 31, 2021 | -28.75% |
| Dec 31, 2020 | -56.71% |
| Sep 30, 2020 | 24.88% |
| Jun 30, 2020 | -41.22% |
| Mar 31, 2020 | 58.56% |
| Dec 31, 2019 | 87.81% |
| Sep 30, 2019 | 62.19% |
| Jun 30, 2019 | 92.46% |
| Mar 31, 2019 | -45.90% |
| Dec 31, 2018 | 54.24% |
| Sep 30, 2018 | 30.54% |
| Jun 30, 2018 | 48.98% |
| Mar 31, 2017 | -55.80% |
| Sep 30, 2016 | -66.56% |
| Jun 30, 2016 | -54.72% |
| Mar 31, 2016 | -57.17% |
| Dec 31, 2015 | -29.45% |
| Sep 30, 2015 | -31.67% |
| Mar 31, 2014 | 2.88% |
| Sep 30, 2013 | 6.60% |
| Jun 30, 2013 | 15.91% |